The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Veterinary Pharmaceutical Drug Market Research Report 2024
Synopsis
Veterinary medicine is the branch of medicine that deals with the prevention, diagnosis and treatment of disease, disorder and injury in non-human animals. The scope of veterinary medicine is wide, covering all animal species, both domesticated and wild, with a wide range of conditions which can affect different species.
The global Veterinary Pharmaceutical Drug market was valued at US$ 23520 million in 2023 and is anticipated to reach US$ 33280 million by 2030, witnessing a CAGR of 5.1% during the forecast period 2024-2030.
The animal drugs market is projected to experience significant growth in the foreseeable future. Factors such as increasing pet ownership, growing demand for livestock products, and the prevalence of animal diseases drive market growth. The market is highly competitive, with several pharmaceutical companies involved in the production and distribution of animal drugs. However, challenges such as stringent regulatory requirements, concerns about antibiotic resistance, and limited accessibility in developing regions may hinder market expansion. Nonetheless, the animal drugs market holds promising opportunities, fueled by the need for effective treatments and preventive measures for animal health, and the growing focus on animal welfare and food safety.
This report aims to provide a comprehensive presentation of the global market for Veterinary Pharmaceutical Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Pharmaceutical Drug.
Report Scope
The Veterinary Pharmaceutical Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Veterinary Pharmaceutical Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary Pharmaceutical Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boehringer Ingelheim
Zoetis
Elanco Animal Health
Merck Animal Health
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Meiji
Ouro Fino Saude
Animalcare Group
Parnell
Segment by Type
Oral
Injection
Other
Segment by Application
Companion Animals
Livestock Animals
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Veterinary Pharmaceutical Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Veterinary medicine is the branch of medicine that deals with the prevention, diagnosis and treatment of disease, disorder and injury in non-human animals. The scope of veterinary medicine is wide, covering all animal species, both domesticated and wild, with a wide range of conditions which can affect different species.
The global Veterinary Pharmaceutical Drug market was valued at US$ 23520 million in 2023 and is anticipated to reach US$ 33280 million by 2030, witnessing a CAGR of 5.1% during the forecast period 2024-2030.
The animal drugs market is projected to experience significant growth in the foreseeable future. Factors such as increasing pet ownership, growing demand for livestock products, and the prevalence of animal diseases drive market growth. The market is highly competitive, with several pharmaceutical companies involved in the production and distribution of animal drugs. However, challenges such as stringent regulatory requirements, concerns about antibiotic resistance, and limited accessibility in developing regions may hinder market expansion. Nonetheless, the animal drugs market holds promising opportunities, fueled by the need for effective treatments and preventive measures for animal health, and the growing focus on animal welfare and food safety.
This report aims to provide a comprehensive presentation of the global market for Veterinary Pharmaceutical Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Pharmaceutical Drug.
Report Scope
The Veterinary Pharmaceutical Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Veterinary Pharmaceutical Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary Pharmaceutical Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boehringer Ingelheim
Zoetis
Elanco Animal Health
Merck Animal Health
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Meiji
Ouro Fino Saude
Animalcare Group
Parnell
Segment by Type
Oral
Injection
Other
Segment by Application
Companion Animals
Livestock Animals
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Veterinary Pharmaceutical Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Veterinary Pharmaceutical Drug Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Oral
1.2.3 Injection
1.2.4 Other
1.3 Market by Application
1.3.1 Global Veterinary Pharmaceutical Drug Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Companion Animals
1.3.3 Livestock Animals
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Veterinary Pharmaceutical Drug Market Perspective (2019-2030)
2.2 Veterinary Pharmaceutical Drug Growth Trends by Region
2.2.1 Global Veterinary Pharmaceutical Drug Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Veterinary Pharmaceutical Drug Historic Market Size by Region (2019-2024)
2.2.3 Veterinary Pharmaceutical Drug Forecasted Market Size by Region (2025-2030)
2.3 Veterinary Pharmaceutical Drug Market Dynamics
2.3.1 Veterinary Pharmaceutical Drug Industry Trends
2.3.2 Veterinary Pharmaceutical Drug Market Drivers
2.3.3 Veterinary Pharmaceutical Drug Market Challenges
2.3.4 Veterinary Pharmaceutical Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Veterinary Pharmaceutical Drug Players by Revenue
3.1.1 Global Top Veterinary Pharmaceutical Drug Players by Revenue (2019-2024)
3.1.2 Global Veterinary Pharmaceutical Drug Revenue Market Share by Players (2019-2024)
3.2 Global Veterinary Pharmaceutical Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Veterinary Pharmaceutical Drug Revenue
3.4 Global Veterinary Pharmaceutical Drug Market Concentration Ratio
3.4.1 Global Veterinary Pharmaceutical Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Veterinary Pharmaceutical Drug Revenue in 2023
3.5 Veterinary Pharmaceutical Drug Key Players Head office and Area Served
3.6 Key Players Veterinary Pharmaceutical Drug Product Solution and Service
3.7 Date of Enter into Veterinary Pharmaceutical Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Veterinary Pharmaceutical Drug Breakdown Data by Type
4.1 Global Veterinary Pharmaceutical Drug Historic Market Size by Type (2019-2024)
4.2 Global Veterinary Pharmaceutical Drug Forecasted Market Size by Type (2025-2030)
5 Veterinary Pharmaceutical Drug Breakdown Data by Application
5.1 Global Veterinary Pharmaceutical Drug Historic Market Size by Application (2019-2024)
5.2 Global Veterinary Pharmaceutical Drug Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Veterinary Pharmaceutical Drug Market Size (2019-2030)
6.2 North America Veterinary Pharmaceutical Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Veterinary Pharmaceutical Drug Market Size by Country (2019-2024)
6.4 North America Veterinary Pharmaceutical Drug Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Veterinary Pharmaceutical Drug Market Size (2019-2030)
7.2 Europe Veterinary Pharmaceutical Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Veterinary Pharmaceutical Drug Market Size by Country (2019-2024)
7.4 Europe Veterinary Pharmaceutical Drug Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Veterinary Pharmaceutical Drug Market Size (2019-2030)
8.2 Asia-Pacific Veterinary Pharmaceutical Drug Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Veterinary Pharmaceutical Drug Market Size by Region (2019-2024)
8.4 Asia-Pacific Veterinary Pharmaceutical Drug Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Veterinary Pharmaceutical Drug Market Size (2019-2030)
9.2 Latin America Veterinary Pharmaceutical Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Veterinary Pharmaceutical Drug Market Size by Country (2019-2024)
9.4 Latin America Veterinary Pharmaceutical Drug Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Veterinary Pharmaceutical Drug Market Size (2019-2030)
10.2 Middle East & Africa Veterinary Pharmaceutical Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Veterinary Pharmaceutical Drug Market Size by Country (2019-2024)
10.4 Middle East & Africa Veterinary Pharmaceutical Drug Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Company Detail
11.1.2 Boehringer Ingelheim Business Overview
11.1.3 Boehringer Ingelheim Veterinary Pharmaceutical Drug Introduction
11.1.4 Boehringer Ingelheim Revenue in Veterinary Pharmaceutical Drug Business (2019-2024)
11.1.5 Boehringer Ingelheim Recent Development
11.2 Zoetis
11.2.1 Zoetis Company Detail
11.2.2 Zoetis Business Overview
11.2.3 Zoetis Veterinary Pharmaceutical Drug Introduction
11.2.4 Zoetis Revenue in Veterinary Pharmaceutical Drug Business (2019-2024)
11.2.5 Zoetis Recent Development
11.3 Elanco Animal Health
11.3.1 Elanco Animal Health Company Detail
11.3.2 Elanco Animal Health Business Overview
11.3.3 Elanco Animal Health Veterinary Pharmaceutical Drug Introduction
11.3.4 Elanco Animal Health Revenue in Veterinary Pharmaceutical Drug Business (2019-2024)
11.3.5 Elanco Animal Health Recent Development
11.4 Merck Animal Health
11.4.1 Merck Animal Health Company Detail
11.4.2 Merck Animal Health Business Overview
11.4.3 Merck Animal Health Veterinary Pharmaceutical Drug Introduction
11.4.4 Merck Animal Health Revenue in Veterinary Pharmaceutical Drug Business (2019-2024)
11.4.5 Merck Animal Health Recent Development
11.5 Virbac
11.5.1 Virbac Company Detail
11.5.2 Virbac Business Overview
11.5.3 Virbac Veterinary Pharmaceutical Drug Introduction
11.5.4 Virbac Revenue in Veterinary Pharmaceutical Drug Business (2019-2024)
11.5.5 Virbac Recent Development
11.6 Dechra Veterinary Products
11.6.1 Dechra Veterinary Products Company Detail
11.6.2 Dechra Veterinary Products Business Overview
11.6.3 Dechra Veterinary Products Veterinary Pharmaceutical Drug Introduction
11.6.4 Dechra Veterinary Products Revenue in Veterinary Pharmaceutical Drug Business (2019-2024)
11.6.5 Dechra Veterinary Products Recent Development
11.7 Ceva
11.7.1 Ceva Company Detail
11.7.2 Ceva Business Overview
11.7.3 Ceva Veterinary Pharmaceutical Drug Introduction
11.7.4 Ceva Revenue in Veterinary Pharmaceutical Drug Business (2019-2024)
11.7.5 Ceva Recent Development
11.8 Vetoquinol
11.8.1 Vetoquinol Company Detail
11.8.2 Vetoquinol Business Overview
11.8.3 Vetoquinol Veterinary Pharmaceutical Drug Introduction
11.8.4 Vetoquinol Revenue in Veterinary Pharmaceutical Drug Business (2019-2024)
11.8.5 Vetoquinol Recent Development
11.9 Meiji
11.9.1 Meiji Company Detail
11.9.2 Meiji Business Overview
11.9.3 Meiji Veterinary Pharmaceutical Drug Introduction
11.9.4 Meiji Revenue in Veterinary Pharmaceutical Drug Business (2019-2024)
11.9.5 Meiji Recent Development
11.10 Ouro Fino Saude
11.10.1 Ouro Fino Saude Company Detail
11.10.2 Ouro Fino Saude Business Overview
11.10.3 Ouro Fino Saude Veterinary Pharmaceutical Drug Introduction
11.10.4 Ouro Fino Saude Revenue in Veterinary Pharmaceutical Drug Business (2019-2024)
11.10.5 Ouro Fino Saude Recent Development
11.11 Animalcare Group
11.11.1 Animalcare Group Company Detail
11.11.2 Animalcare Group Business Overview
11.11.3 Animalcare Group Veterinary Pharmaceutical Drug Introduction
11.11.4 Animalcare Group Revenue in Veterinary Pharmaceutical Drug Business (2019-2024)
11.11.5 Animalcare Group Recent Development
11.12 Parnell
11.12.1 Parnell Company Detail
11.12.2 Parnell Business Overview
11.12.3 Parnell Veterinary Pharmaceutical Drug Introduction
11.12.4 Parnell Revenue in Veterinary Pharmaceutical Drug Business (2019-2024)
11.12.5 Parnell Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
